Medical Devices industry venture financing deals total $1.55bn in US in March 2022

Total medical devices industry venture financing deals worth $1.55bn were announced in the US in March 2022, led by $200m venture financing of DNAnexus, according to GlobalData’s deals database.

The value marked a flat growth over the previous month of $1.55bn and a flat growth when compared with the last 12-month average of $1.55bn.

The US held a 72.77% share of the global medical devices industry venture financing deal value that totalled $2.13bn in March 2022.

In terms of venture financing deal activity, the US recorded 85 deals during March 2022, marking an increase of 8.97% over the previous month and a rise of 11.84% over the 12-month average.

US medical devices industry venture financing deals in March 2022: Top deals

The top five medical devices industry venture financing deals accounted for 37.9% of the overall value during March 2022.

The combined value of the top five medical devices venture financing deals stood at $585m, against the overall value of $1.55bn recorded for the month.

The top five medical devices industry venture financing deals of March 2022 tracked by GlobalData were:

1) Blackstone Growth,Foresite Capital Management,GV Management Co,Innovatus Capital Partners,Northpond Ventures and Perceptive Advisors $200m venture financing deal with DNAnexus

2) The $125m venture financing of BillionToOne by Adams Street Partners,Baillie Gifford,Civilization Ventures,Fifty Years Fund,Hummingbird Ventures,Libertus Capital,NeoTribe Ventures,Norwest Venture Partners,Pacific 8 Ventures and Time BioVentures

3) Artiman Ventures,Blue Water Life Science Advisors,Cedars-Sinai Medical Center,Healthcare of Ontario Pension Plan,John Doerr,ND Capital,Nissim Capital,Ping An Voyager Partners and Pitango Venture Capital $100m venture financing deal with Visby Medical

4) The $80m venture financing of Sherlock Biosciences by Catalio Capital Management,First Albany Capital,Good Ventures,Illumina Ventures,Northpond Ventures and Novalis LifeSciences

5) Ally Bridge Group,Ascension Health Ventures,Catalio Capital Management,Hillenbrand Capital,Johnson & Johnson Innovation – JJDC,KCK Group,Pfizer Venture Investments,PSP INVESTMENTS,Sixty Degree Capital,T Rowe Price Associates,The Rise Fund and Venrock Healthcare Capital Partners $80m venture financing deal with RefleXion Medical